glp-1 drugs safety Are GLP-1s Safe? Everything You Need to Know About Popular GLP-1 weight-loss drugs linked
Description
Eat less, move more is not a long-term weight management solution
Eli Lillys first nine months of 2025 underscored the scale of the GLP-1 surge: Mounjaro and Zepbound generated $39.5 billion in revenue and surpasses Mercks Keytruda as the worlds best-selling medicine[5]
The GLP-1 Receptor Agonist market size reached USD 15.25 Billion in 2024 and is expected to register a revenue CAGR of 21.7%
Discover how GLP-1 receptor agonists like semaglutide may reduce inflammation beyond blood sugar control
